ΠΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΌΠΈΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΠΈ Ρ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΠΠΎ Π΄Π°Π½Π½ΡΠΌ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»Π΅ΠΉ ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠ΅ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΈ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ Π½Π΅ΡΠ΅Π΄ΠΊΠΎ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ ΡΡΠΆΠ΅Π»ΡΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΡΠΎΠ΄ΠΎΠ². Π ΡΡΡΡΠΊΡΡΡΠ΅ ΡΡΠΈΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊ i * ΡΠ΄Π΅Π»ΡΠ½ΡΠΉ Π²Π΅Ρ ΠΏΡΠ΅ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΠΈ, ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Π·Π°Π΄Π΅ΡΠΆΠΊΠΈ ΡΠΎΡΡΠ° ΠΏΠ»ΠΎΠ΄Π°, Π²Π½ΡΡΡΠΈΡΡΡΠΎΠ±Π½ΠΎΠΉ Π³ΠΈΠΏΠΎΠΊΡΠΈΠΈ ΠΈ Π°Π½ΡΠ΅Π½Π°ΡΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠ±Π΅Π»ΠΈ ΠΏΠ»ΠΎΠ΄Π°, Π½Π΅Π΄ΠΎΠ½Π°ΡΠΈΠ²Π°Π½ΠΈΡ V Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ, ΠΏΡΠ΅ΠΆΠ΄Π΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΎΡΡΠ»ΠΎΠΉΠΊΠΈ ΠΏΠ»Π°ΡΠ΅Π½ΡΡ. i s ΠΠ΅Π΄ΡΡΠ΅ΠΉ ΠΏΡΠΈΡΠΈΠ½ΠΎΠΉ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΡΠΈΠ°Ρ Π€. ΠΠ΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΡ ΠΈ ΡΠΎΠ΄Ρ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ°. ΠΠ΅ΡΠ΅Π²ΠΎΠ΄ Ρ Π°Π½Π³Π». ΠΠΎΡΠΊΠ²Π°. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°. 1989. 654 Ρ.
- ΠΠ΅ΡΡΠΊΠΈΠ½ Π.Π., ΠΠ°ΡΠ°Π±Π°ΡΠΊΠΈΠ½Π° A.B., Π’ΠΊΠ°ΡΠ΅Π²Π° Π. Π., ΠΠ°ΡΠΈΠ»ΡΠ΅Π²Π° A.B. // ΠΠΠ£ ΠΏΡΠΈ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ 2004, ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠ½ΡΠ΅ΡΠ½Π΅Ρ-ΡΠ΅ΡΡΡΡΠ° http://intensive.ru
- ΠΠΈΡ Π»ΡΠ΅Π²Π° ΠΠ, Π‘ΡΠΏΡΡΠ³Π° ΠΠ. ΠΠ΅ΡΡΠ°ΡΠΈΠΎΠ½Π½Π°Ρ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡ: ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅. // Π’Π΅Ρ. Π°ΡΡ ΠΈΠ². — 1998- 70(10):29—32.
- ΠΠ²Π°Π½ΡΠ½ Π.Π., ΠΡΡΠΊΠΎΠ²ΡΠΊΠΈΠΉ Π‘. Π., ΠΠΎΡΠ΄ΠΈΠ»ΠΎΠ²ΡΠΊΠ°Ρ Π. Π. ΠΈ ΡΠΎΠ°Π²Ρ. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ, ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΈ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ Π³Π΅ΡΡΠΎΠ·Π° (ΠΌΠ΅ΡΠΎΠ΄ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΏΠΎΡΠΎΠ±ΠΈΠ΅). — Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊ: Π‘ΠΠΠ, 2000. 52 Ρ.
- ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈΠ½ΡΠ΅ΡΠΏΡΠ΅ΡΠ°ΡΠΈΡ ΠΠΠ£. ΠΡΡΠ½Π°Π» «ΠΠ°Π±ΠΎΡΠ°ΡΠΎΡΠΈΡ» ΠΠΎΠ΄ ΡΠ΅Π΄. ΠΏΡΠΎΡ. ΠΠΎΠ»Π³ΠΎΠ²Π° Π. Π. № 1 — 2005, ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠ½ΡΠ΅ΡΠ½Π΅Ρ-ΡΠ΅ΡΡΡΡΠ° http://www.vitaldiagnostics.ru/
- ΠΠΎΠ±Π°Π»Π°Π²Π° Π.Π., Π‘Π΅ΡΠ΅Π±ΡΡΠ½Π½ΠΈΠΊΠΎΠ²Π° Π. Π. ΠΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡ ΠΈ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π° ΠΏΡΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ. Π‘Π΅ΡΠ΄ΡΠ΅ Π’. 1, № 5., Ρ.17−19.
- ΠΡΠ΄ΡΡΡΠ΅Π²Π° Π.Π., ΠΠ°ΡΠ΅ΠΉΡΠΈΠΊΠΎΠ² Π. Π., Π‘ΠΈΠ΄ΠΎΡΠ΅Π½ΠΊΠΎ Π. Π. ΠΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΡΠΉ Π³Π΅ΠΌΠΎΡΡΠ°Π·: ΡΠΈΡΡΠ΅ΠΌΠ° ΡΡΠΎΠΌΠ±ΠΎΠΌΠΎΠ΄ΡΠ»ΠΈΠ½Π° ΠΈ Π΅Ρ ΡΠΎΠ»Ρ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π°ΡΠ΅ΡΠΎΡΠΊΠ»Π΅ΡΠΎΠ·Π° ΠΈ Π΅Π³ΠΎ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ // ΠΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ. 2000. — 40. -№ 8. — Π‘.65−70.
- ΠΡΠ»Π°ΠΊΠΎΠ² Π.Π. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΈ. ΠΠΊΡΡΠ΅ΡΡΡΠ²ΠΎ- ΠΈ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡ. -Π.: ΠΠΠΠ’ΠΠ -ΠΠ΅Π΄ΠΈΠ°, 2006. 512 Ρ.
- ΠΡΠ»Π°ΠΊΠΎΠ² Π.Π. Π Π΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠ΅ Π·Π΄ΠΎΡΠΎΠ²ΡΠ΅ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π ΠΎΡΡΠΈΠΈ // ΠΠΊΡΡΠ΅ΡΡΡΠ²ΠΎ ΠΈ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡ. 2002. — № 2. — Π‘.4−7.
- ΠΠ°ΠΊΠ°ΡΠΎΠ² OB, ΠΠΈΠΊΠΎΠ»Π°Π΅Π² ΠΠ, ΠΠΎΠ»ΠΊΠΎΠ²Π° ΠΠ. ΠΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΡ Ρ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ . Π’ΠΎΠ»ΡΠΊΠΎ Π»ΠΈ Π³Π΅ΡΡΠΎΠ·? ΠΠ·Π΄. «ΠΡΠΎΡΠ°Ρ — ΠΌΠ΅Π΄ΠΈΠ°."2006.
- ΠΠΈΠ½ΠΊΠΈΠ½ Π Π, ΠΠ°Π½ΡΠΈΠ½Π° ΠΠ. Π’Π΅ΡΠ΅Π½ΠΈΠ΅ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΡΠΎΠ΄ΠΎΠ² Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ // ΠΠΊΡΡΡΠ°Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½Π°Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ. Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΡ.- Π.:Π ΠΈ, 1986.-Π‘. 98−104.
- ΠΡΡ ΠΈΠ½ H.A., ΠΠΎΠΈΡΠ΅Π΅Π² B.C., ΠΠΎΠ±Π°Π»Π°Π²Π° Π. Π., ΠΠΎΠΈΡΠ΅Π΅Π² C.B., Π€ΠΎΠΌΠΈΠ½ Π. Π. ΠΠ°ΡΠ΄ΠΈΠΎΡΠ΅Π½Π°Π»ΡΠ½ΡΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ: ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΈ ΡΠΎΠ»Ρ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΈ ΠΏΠΎΡΠ΅ΠΊ. Π’Π΅Ρ. Π°ΡΡ . 2004- 6: 39 46
- ΠΡΠ΅ΠΎΠ±ΡΠ°ΠΆΠ΅Π½ΡΠΊΠΈΠΉ Π.Π., ΠΠ°ΡΠ΅Π½ΠΈΡ A.B., Π ΠΎΠΌΠ°Π½ΠΎΠ²Π° Π. Π., ΠΠΈΠΊΡΠ΅Π² Π. Π., Π‘ΠΈΠ΄ΠΎΡΠ΅Π½ΠΊΠΎ Π. Π. // ΠΠΈΠΊΡΠΎΠ°Π»ΡΠ±ΡΠΌΠΈΠ½ΡΡΠΈΡ: Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ (ΡΠ°ΡΡΡ ΠΏΠ΅ΡΠ²Π°Ρ) „Π ΠΎΡΡΠΈΠΉΡΠΊΠΈΠΉ ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΆΡΡΠ½Π°Π»“ № 3 '2000
- Π ΠΎΠ³ΠΎΠ² Π, Π¨ΠΈΠ»ΠΎΠ² Π, ΠΠΎΠ·Π»ΠΎΠ²ΡΠΊΠ°Ρ Π, ΠΠΎΡΠ΄ΠΎΠ²ΡΠΊΠ°Ρ Π. ΠΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΡ ΠΈ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΡ. 2003.
- Π‘Π°Π²Π΅Π»ΡΠ΅Π²Π° Π. Π. Π‘ΠΏΡΠ°Π²ΠΎΡΠ½ΠΈΠΊ ΠΏΠΎ Π°ΠΊΡΡΠ΅ΡΡΡΠ²Ρ, Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΠΏΠ΅ΡΠΈΠ½Π°ΡΠ°Π»ΠΎΠ³ΠΈΠΈ. ΠΠΎΡΠΊΠ²Π°: ΠΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠ΅ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ Π°Π³Π΅Π½ΡΡΠ²ΠΎ „ΠΠΠ“, 2006. — Ρ. 159−161.
- Π‘Π΅ΡΠΎΠ² Π.Π., Π‘ΡΡΠΈΠΆΠ°ΠΊΠΎΠ² Π. Π., ΠΠ°ΡΠΊΠΈΠ½ Π‘. Π. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΌΡ Π°ΠΊΡΡΠ΅ΡΡΡΠ²Ρ. Π.: ΠΠΠ ΠΠΠ, 1997. 436 Ρ.
- Π‘ΠΈΠ΄ΠΎΡΠΎΠ²Π° Π.Π‘., ΠΠ°ΠΊΠ°ΡΠΎΠ² Π. Π. Π€Π΅ΡΠΎΠΏΠ»Π°ΡΠ΅Π½ΡΠ°ΡΠ½Π°Ρ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡ. ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ. Π.: „ΠΠ½Π°Π½ΠΈΠ΅Π“, 2000. — 127 Ρ.
- Π‘ΡΡΠΈΠΆΠ°ΠΊΠΎΠ² Π.Π., ΠΠ³Π½Π°ΡΠΊΠΎ Π. Π., Π‘Π°ΠΌΡΠΎΠ½ΡΠ½ Π. Π., ΠΡΠ±ΠΎΠ»Π°Π·ΠΎΠ² Π. Π. ΠΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ ΠΊ Π²ΡΠ±ΠΎΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ Π°ΠΊΡΡΠ΅ΡΡΠΊΠΎΠΉ ΡΠ°ΠΊΡΠΈΠΊΠΈ Ρ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ Ρ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ΅ΠΉ // ΠΠΎΠΏΡΠΎΡΡ Π³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π°ΠΊΡΡΠ΅ΡΡΡΠ²Π° ΠΈ ΠΏΠ΅ΡΠΈΠ½Π°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. — 2004. № 1. — Π‘.7−15.
- Π‘ΡΡΠΈΠΆΠ°ΠΊΠΎΠ² Π.Π., ΠΡΡΠ°Π΅Π² Π. Π., Π’ΠΈΠΌΠΎΡ ΠΈΠ½Π° Π’. Π€. ΠΠ°ΡΡΡΠ΅Π½ΠΈΡ ΠΌΠ°ΡΠ΅ΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΈ ΠΏΠ»ΠΎΠ΄ΠΎΠ²ΠΎΠΉ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ Π³Π΅ΡΡΠΎΠ·Π°// ΠΠ΅ΡΡΠ½ΠΈΠΊ Π ΠΠΠ.-2001 .-№ 8.- Π‘.44−48.
- Π‘ΡΠΏΡΡΠ³Π° ΠΠ. ΠΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Ρ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ : ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅. Π., 1997.
- Π§Π°Π·ΠΎΠ²Π° Π.Π., ΠΡΡΠΊΠ° Π. Π., ΠΠΎΡΠΎΠ΄Π½Π΅Π²Π° Π. Π. ΠΈ Π΄Ρ. ΠΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ. Π’Π΅Ρ. Π°ΡΡ . 2002- 10: 7 12
- Π¨Π΅Ρ ΡΠΌΠ°Π½ ΠΠ. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΡΠΊΡΡΡΠ°Π³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ Ρ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ . Π., 1999.
- Π¨ΠΈΡΠΌΠ°Π½ Π.Π. ΠΡΠ΅ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΡ, ΡΠΊΠ»Π°ΠΌΠΏΡΠΈΡ, HELLP ΡΠΈΠ½Π΄ΡΠΎΠΌ. -ΠΠ΅ΡΡΠΎΠ·Π°Π²ΠΎΠ΄ΡΠΊ: ΠΠ·-Π²ΠΎ „ΠΠ½ΡΠ΅Π»Π’Π΅ΠΊ“, 2003. — 432 Ρ.
- Agewall S, Wikstrand J, Linngmann S, et al. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Amer J Cardiol 1997−80:164−9.
- Agrawal Π., Wolf K, BergerA., Luft F.C. // Effect of antihypertensive treatment on qualitative estimates of microalbuminuria J. Human Hypertension, 1996- 10:551−555.
- Arnal JF., Michel JB., Harrison DG. Nitric oxide in the pathogenesis of hypertension. Curr Opin Nephrol Hypertens 1995 Mar-4(2): 182−8
- Bar J. et al. // Microalbuminuria in early pregnancy in normal and high-risk patients 1996
- Beghetti M, Tissot C. Semin Pulmonary arterial hypertension inlcongenital heart diseases. Respir Crit Care Med. 2009 Aug-30(4):421−8. Epub 2009 Jul 241
- Bell DS. Diabetes: a cardiac condition manifesting as hyperglycemia. Endocr Pract. 2008 Oct-14(7):924−32. Review.
- Berton G., Cordiano R., Palmieri R. et al. Microalbuminuria during acute myocardial infarction. A strong predictor for 1-year mortality. Eur. Heart. J. 2001−22:1466−1475
- Beyer-Westendorf J, Seitz W, Jabs N, Bramlage P, Kuhlisch E, Julius U, Bornstein SR, Schellong SM. Nitric oxide and endothelin after lipid apheresis a pilot study. Atheroscler Suppl. 2009 Dec 29−10(5):70−73
- Biesenbach G., Zazgornik J. et al. Abnormal increases in urinary albumin excretion during pregnancy in IDDM women with pre-existing Microalbuminuria — 1994
- Bigazzi R., Bianchi S., Baldari D., Campese V.M. // Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J. Hypertension, 1998- 16 (9): 1325−1333.
- Bonnet F., Marre M., Halimi J.M. et al. Waist circumference and the metabolic syndrome predict the development of elevated' albuminuria in non-diabetic subjects: the DESIR Study. J. Hypertens. 2006- 24 (6): 1157 -1163
- Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S. et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler. Thomb. Vase. Biol. 1999- 19: 1992 1997
- Caetano M., Ornstein M.P., Von Dadelszen P. et al. A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy//Hypertens Pregnancy. 2004- 23(1). P.61−74.
- Cerasola G, Guarneri M, Cottone S. G Inflammation, oxidative stress and kidney function in arterial hypertension Ital Nefrol. 2009 Jul-Aug-26 Suppl 46:8−13
- Chandler DL, Llinas MT, Reckelhoff JF, LaMarca B, Speed J, Granger JP. Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant rats. Am J Hypertens. 2009 0ct-22(10):l 1*15−9. Epub 2009 Jul 23
- Chen J, Yu YH, Wang ZJ, Qin W, Zhang Q. Nan Fang Yi Ke Da Xue Xue Bao. Relationship between preeclampsia umbilical blood flow and perinatal outcomes 2009 Apr-29(4):745
- Chen Q, Chen L, Liu B, Vialli C, Stone P, Ching LM, Chamley L. The role of autocrine TGFbetal in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre-eclampsia. J Pathol. 2010 Jan 21
- Chobanian A.V., Bakris G.L., Black H.R. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC VI Report. J.A.M.A. 2003- 289:2560−2571
- Cicco G, Cicco S. The influence of oxygen supply, hemorheology and microcirculation in the heart and vascular systems. Adv Exp Med Biol. 2010
- Cirillo M., Senigalliesi L., Laurenzi M. et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch. Intern. Med. 1998- 158 (17): 1933 1939
- Cirillo M., Stellato D., Laurenzi M. et al. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int. 2000- 58(3): 1211 1218
- Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997−37:240−249.
- Dobre D, Nimade S, de Zeeuw D. Albuminuria in heart failure: what do we really know? Curr Opin Cardiol. 2009 Mar-24(2): 148−54.
- Draisma A, Dorresteijn MJ, Bouw MP, van der Hoeven JG, Pickkers P. The role of cytokines and inducible nitric oxide synthase in endotoxemia-induced endothelial dysfunction. J Cardiovasc Pharmacol. 2010 Mar 6.
- Drexler H. Endothelial dysfunction: clinical implications // Prog. Cardiovascular Dis. 1997. V. 39. P. 287−324.
- Duley L. Preeclampsia and hypertension//Clin Evid. 2004, Dec-(12). -P.2016 -2034.
- Dzau V, Bernstein K, Celermaier D, et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 2001−88(suppl. L):l-20.
- Ekbom P., Damm P. et al. // Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes 2000
- Eriey C., Haefele U., Haune N. et al. // Microalbuminuria in essential hypertension. //Hypertension, 2000- 21:810−815.
- Foidart JM, Noel A, Chantraine F, Lorquet S, Petit P, Munaut C, Berndt S, Pequeux C, Schaaps JP. Defective placental implantation and its effects on maternal endothelial function Bull Acad Natl Med. 2009 May- 193(5): 1059−64- discussion 1064−6, 1067−8.
- Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 2010 Mar 21.
- Fugate SR, Chow GE. Eclampsia. American College of Obstetricians and Gynecologists. 04.09.2002.
- Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in type 2 diabetic nephropathy. Ren Fail. 2009−31(3):207−10.
- Gifford RW, August PA, Cunningham G. Working Group Report on High Blood Pressure in Pregnancy. July 2000. 38 p.
- Gilbert JS, Gilbert SA, Arany M, Granger JP. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension. 2009 Feb-53(2):399−403. Epub 2008 Dec 15.
- Gilbert JS, Nijland MJ, Knoblich P.Expert. Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. Rev Cardiovasc Ther. 2008 Nov-6(10): 1367−77
- Grill S, Rusterholz C, Zanetti-Dallenbach R, Tercanli S, Holzgreve W, Hahn S, Lapaire O. Potential markers of preeclampsia—a review. Reprod Biol Endocrinol. 2009 Jul 14−7:70. Review.
- Hampl V, Jakoubek V. Regulation of fetoplacental vascular bed by hypoxia. Physiol Res. 2009−58 Suppl 2: S87−93
- Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai BM, Curet LB, Catalano PM, Morris CD. Pregnancy outcomes in healthy nulliparas, who developed hypertension. Am J Obstet Gynecol 2000- 95: 24 28.
- Hebisch G. Hypertension and pregnancy//Schweiz Rundsch Med Prax. -2003, Dec- 92(50). -P.2137 2143.
- Hirata Y, Naga ta D, Suzuki E, Nishimatsu H, Suzuki J, Nagai R. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int Heart J. 2010 Jan-51(l):l-6.
- Humar R, Zimmerli L, Battegay E. J Hum Angiogenesis and hypertension: an update. Hypertens. 2009 Dec-23(12):773−82. Epub 2009 Aug 13.
- Intensive Care Med 2007- advance online publication. Cardiosite.ru -2007
- J. Bar, B. Kaplan, C. Wittenberg, A. Erman, G. Boner, Z. Ben-Rafael and M. Hod Microalbuminuria after pregnancy complicated by pre-eclampsia -2000
- Jager A., Kostense P.J., Nijpels G. et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler. Thromb. Vase. Biol. 2001- 21 (1): 74 81
- Jones C.A., Francis M.E., Eberhardt M.S. et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am. J. Kidney. Dis. 2002- 39: 445 459
- Keane W.F., Eknoyan G: Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004−1010, 1999
- Knight E.L., Kramer H.M., Curhan G.C. High-normal blood pressure and microalbuminuria. Am. J. Kidney Dis. 2003- 41:588−595
- LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-{alpha}. Hypertension. 2005a-46: 10 221 025.
- Lastra G., Manrique C., Sowers J.R. et al. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv. Chronic Kidney Dis. 2006- 13 (4): 365 373
- Levy AS, Chung JC, Kroetsch JT, Rush JW. Nitric oxide and coronary vascular endothelium adaptations in hypertension. Vase Health Risk Manag. 2009−5:1075−87. Epub 2009 Dec 29
- Liese A.D., Hense H.W., Brown A.A. et al. Microalbuminuria, central adiposity and hypertension in the non-diabetic' urban population of the MONICA Augsburg survey 1994/95. J. Hum. Hypertens. 2001- 15: 799 -804
- Llinas MT, Alexander BT, Seedek M, Abram SR, Crell A, Granger JP. Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. Am J Hypertens. 2002−15:793−797.
- Luscher T.F., Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995 Dec-118 Suppl: S81−90
- Lusher T.F., Barton M. Biology of the endothelium. Clin. Cardiol, 1997- 10 (suppl 11), II-3−13−10.
- Masaidi M, Cuspidi C, Giudici V, Negri F, Sala C, Zanchetti A, Grassi G, Mancia G. Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension? J Hypertens: 2009 Jun-27(6): 1277−83.
- Mimran A., Ribstein. J. // Microalbuminuria, in essential hypertension, Clin. Exper. Hypertension, 1993- 15(6): 1061−1067.
- Misiani R., Marchesi D. et al. // Urinary albumin excretion in normal-pregnancy and pregnancy-induced hypertension: — 1991
- Mogenstein C.E., Keane W.F., Bennett P: H. et al. // Prevention of diabetic renal- disease with special reference to microalbuminuria Lancet, 1995- 346 (8982): 1080−1084.
- Moss MB, Siqueira MA, Mann GE, Brunini- TM, Mendes-Ribeiro AC. Platelet aggregation in arterial* hypertension: is there a nitric oxide-ureaconnection? Clin Exp Pharmacol Physiol. 2010 Feb-37(2): 167−72. Epub 2009 Jun 29.
- Mulrow C D, Chiquette E, Ferrer R L, Sibai B M, Stevens K R, Harris M, Montgomery K A, Stamm K. Management of chronic hypertension during pregnancy. Rockville, MD, USA: Agency for Healthcare Research and Quality. Evidence Report/Tech. 2000. 1−208.
- Nanayakkara PW, Gaillard CA. Vascular disease and chronic renal failure: new insights. Neth J Med. 2010 Jan-68(l):5−14.
- Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res. 2009 Aug-32(8):l 103−8. Epub 2009 Aug 29
- Ndayambaje EB, Nakalembe M, Kaye DK. Factors associated with persistent hypertension after puerperium among women with pre-eclampsia/eclampsia in Mulago Hospital, Uganda. BMC Pregnancy Childbirth. 2010 Mar 12−10(1):12
- Noll G., Tschudi M., Nava E., Luscher TF. Endothelium and high blood pressure. Int J Microcirc Clin Exp 1997 Oct-17(5):273−9
- Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Am J Obstet Gynecol 2000- 96:950 5.
- Paciencia M, Dolley P, Jeanne-Pasquier C, Jacob B, Sadfi A, Leseigneur P, Dreyfus M. Acute-placental dysfunction by villous-maturation defect and late-fetal mortality J Gynecol Obstet Biol Reprod (Paris). 2008 Oct-37(6):602−7. Epub 2008
- Parving H.H. // Microalbuminuria in essential hypertension J. Hypertension, 1996- 14: S89-S94.
- Paternoster D.M., Stella A. et al. // Predictive markers of preeclampsia in hypertensive disorders of pregnancy 1999
- Pedrinelli R., Dell’Omo G., Penno G. et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension. 2000- 35 (1 Pt. 1): 48 54
- Peng M, Ding Y, Yu L, Zhou C. Zhong Nan Da Xue Xue Bao Yi Xue Ban. Change of HIF-1 alpha protein expression in the placenta bed and concentration of vWF in maternal peripheral blood of pre-eclampsia.2010 Feb-35(2): 134−9
- Pereira A.C., Gersgorin H.C., Paula T.A. et al. Perinatal outcome in the different clinical forms of hypertension during pregnancy//Rev Assoc Med Bras. 2006 Nov-Dec- 52(6):390−4.
- Portoles Perez J, Cuevas-Bou X. Cardiorenal syndrome. Nefrologia. 2008−28 Suppl 3:29−32.
- Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004- 44:374−380.
- Ramirez RJJ, Hubel CA, Novak J, DiCianno JR, Kagan VE, Gandley RE. Moderate ascorbate deficiency increases myogenic tone of arteries from pregnant but not virgin ascorbate-dependent rats. Hypertension. 2006−47: 454−460.
- Ramirez-Velez R, Aguilar AC, Mosquera M, Garcia RG, Reyes LM, Lopez-Jaramillo P.Trials. Clinical trial to assess the effect of physical exercise on endothelial function and insulin resistance in pregnant women.2009 Nov 17- 10:104.
- Ray J.G., Burrows R.F., Burrows E.A. et al. MOS HIP: McMaster outcome study of hypertension in pregnancy// Early Hum Dev. 2001 Sep- 64(2): 129−43.
- Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE. Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis. 2009 Feb-53(2):281−9. Epub 2008 Dec 19.
- Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 2003−22:109−27.
- Roberts L, LaMarca B, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006−47: 615— 618.
- Rocco A, Heerlein K, Diedler J, Sykora M, Barrows R, Hacke W, Steiner T. Microalbuminuria in cerebrovascular disease: a modifiable risk factor? Int J Stroke. 2010 Feb-5(l):30−4.
- Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res. 2009 Oct 13
- Schade D, Kotthaus J, Clement B. Modulating the NO generating system from a medicinal chemistry perspective: Current trends and therapeutic options in cardiovascular disease. Pharmacol Ther. 2010 Mar 1
- Seely EW. Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. / Clin Endoc 1999- 84: 1858−61.
- Seely EW. Hypertension in pregnancy. J Clin Endoc 2005- 12: 1678
- Shah DM. Role of the renin-angiotensin system1 in the pathogenesis of preeclampsia Am J Physiol Renal Physiol. 2005−288:F614-F625.
- Shankar S.S., Steinberg H.O. Obesity and endothelial dysfunction. Semin. Vase. Med. 2005- 5: 56 64
- Shimokawa H. Endothelial dysfunction-in hypertension. J Atheroscler Thromb 1998−4(3): 118−27
- Sibai BM. Diagnosis, prevention and management of eclampsia- American College of Obstetricians-and Gynecologists. 2005- 105: 402 -410.
- Sibai BM. Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension. 2008 Nov-52(5):805−6. Epub 2008 Sep 29.
- Sibai BM. Risk, factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med. 2000−9(l):62−5.
- Soares VM, de Souza KV, Freygang TC, Correa- V, Saito MR.Rev. Maternal mortality due to pre-eclampsia/eclampsia in a state in southern β’Brazili Bras Ginecol Obstet. 2009 Nov-31(11):566−73
- Solbu MD, Jenssen TG, Eriksen BO, Toft I. Changes in insulin sensitivity, renal- function, and markers of endothelial dysfunction inhypertension—the impact of microalbuminuria: a 13-year follow-up study. Metabolism. 2009 Mar-58(3):408−15.
- Solomon CG, Carroll JS, Okamura K, Graves SW, Seely EW. Higher cholesterol and insulin levels are associated with, increased risk for pregnancy-induced hypertension. Am J Hypertens. 1999 12:276 — 282.
- Stortoni P, Cecati M, Giannubilo SR, Sartini D, Turi A, Emanuelli M, Tranquilli AL. Placental thrombomodulin^ expression in recurrent1 miscarriage. Reprod Biol Endocrinol». 2010 Jan 5−8:1.
- Swarup J., Balkundi D., Brozanski B. et al. Effect of preeclampsia on blood pressure in newborn very low birth weight infants//Hypertens Pregnancy. 2005- 24(3). -P.223 — 234.
- Taddei S., Salvetti A. Pathogenetic factors in hypertension. Endothelial factors. Clin Exp Hypertens 1996 Apr-May- 18(3−4):323−35
- Taddei S., Virdis A., Ghiadoni L., Salvetti A. The role of endothelium in human hypertension Curr Opin Nephrol Hypertens 1998 Mar-7(2):203−9
- Titov VN. Klin Phylogenetic, pathogenetic fundamentals and a role of clinical biochemistry in-classification of arterial hypertension Lab Diagn. 2009 0ct-(10):3−13.
- Tuder RM, Abman SH- Braun T, Capron F, Stevens T, Thistlethwaite PA, Haworth SG. Development and pathology of pulmonary-hypertension. J Am Coll Cardiol. 2009 Jun 30−54(1 Suppl):S3−9. Review.
- Ueda S, Yamagishi SI, Okuda S. New pathways to renal damage: role of ADMA in retarding renal disease progression. J Nephrol. 2010 Mar 24
- UK Prospective Diabetes Study (UKPDS) Group // Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998- 352(9131): 837−853.
- Valappil N1, Jacobs DR, Duprez DA, Gross MD, Arnett DK, Glasser S. Association between Endothelial Biomarkers and Arterial Elasticity in
- Young Adults The CARDIA Study. I Am Soc Hypertens. 2008 Apr-2(2):70−79.152., Valensi P., Busy M., Combes MiE., Atali LR: // Microalbuminuria and hypertension in obese patients. Arch. Mal. Coeur. Vaiss., 1992- 85:1193−1195.
- Valensise H, Vasapollo B, Gagliardi G, Novell! G. Early and. late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008 Nov-52(5):873−80. Epub 2008 Sep 29-
- Van Zwieten PA. Endothelial dysfunction in hypertension. A critical evaluation. Blood Press Suppl 1997−2:67−70
- Vanhoutte PMi, Boulanger CM. Endothelium-dependent responses inhypertension. Hypertens Res 1995 Jun- 18(2):87−98
- Vigil-Dc Gracia- P., Montufar-Rueda C., Smith A. Pregnancy and severe chronic hypertension: maternar outcome//HypertenS' Pregnancy: -2004, Nov, 23(3),-P: 285−293.. '
- Walsh SK, English FA, Johns EJ, Kenny LC. Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. Hypertension. 2009 Aug-54(2): 345−51. Hpub 2009. Jun 29
- Woods LL. Importance of prostaglandins in hypertension during reduced uteroplacental perfusion pressure. Am J Physiol. 1989−257:R1558-R1561.
- Yeboah J, Crouse JR, Bluemke DA, Lima JA, Polak JF, Burke GL, Herrington DM. Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA). J Hum Hypertens. 2010 Mar 1
- Young ΠΠ‘, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010−5:173−92.
- Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003−22:203−12.
- Zhang YL, Liu JT, Gao JS, Yang JQ, Bian XM. Influential and prognostic factors of small for gestational age infants. Med J (Engl). 2009 Feb 20−122(4):386−9.
- Zhao W, Qiao J, Zhang Q, Zhao Y, Chen Q. Growth Factors. Levels of antiangiogenic factors in preeclamptic pregnancies. 2010 Mar 10.